2024 Q4 Form 10-Q Financial Statement

#000119983524000522 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $2.574K $0.00
YoY Change
Cost Of Revenue $1.061K
YoY Change
Gross Profit $1.513K
YoY Change
Gross Profit Margin 58.78%
Selling, General & Admin $59.50K
YoY Change 64.46%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $70.00
YoY Change -30.0%
% of Gross Profit
Operating Expenses $52.77K $59.57K
YoY Change -11.41% 64.22%
Operating Profit -$51.26K -$59.57K
YoY Change -13.95% 64.22%
Interest Expense -$1.770K
YoY Change -32.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$49.56K -$61.34K
YoY Change -19.21% 57.68%
Income Tax
% Of Pretax Income
Net Earnings -$49.56K -$61.34K
YoY Change -19.21% 57.68%
Net Earnings / Revenue -1925.41%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 15.69M shares 15.06M shares 14.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.23K
YoY Change -70.04%
Cash & Equivalents $1.988K $13.23K
Short-Term Investments
Other Short-Term Assets $46.69K
YoY Change 438.52%
Inventory $125.7K $105.4K
Prepaid Expenses
Receivables $1.783K
Other Receivables
Total Short-Term Assets $144.6K $165.4K
YoY Change -12.55% 213.01%
LONG-TERM ASSETS
Property, Plant & Equipment $2.774K $861.00
YoY Change 222.18% -26.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.774K $861.00
YoY Change 222.18% -26.85%
TOTAL ASSETS
Total Short-Term Assets $144.6K $165.4K
Total Long-Term Assets $2.774K $861.00
Total Assets $147.4K $166.2K
YoY Change -11.33% 207.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.77K $1.280K
YoY Change 1210.39% -89.82%
Accrued Expenses $4.626K $2.236K
YoY Change 106.89% -63.3%
Deferred Revenue
YoY Change
Short-Term Debt $64.61K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $104.2K $68.13K
YoY Change 52.97% 208.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $104.2K $68.13K
Total Long-Term Liabilities $0.00
Total Liabilities $68.13K
YoY Change 208.14%
SHAREHOLDERS EQUITY
Retained Earnings -$641.9K -$483.6K
YoY Change 32.72% 50.02%
Common Stock $1.569K $1.465K
YoY Change 7.1% 18.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.17K $98.10K
YoY Change
Total Liabilities & Shareholders Equity $147.4K $166.2K
YoY Change -11.33% 207.78%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$49.56K -$61.34K
YoY Change -19.21% 57.68%
Depreciation, Depletion And Amortization $70.00
YoY Change -30.0%
Cash From Operating Activities -$70.08K
YoY Change 55.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 53.90K
YoY Change 33.61%
NET CHANGE
Cash From Operating Activities -70.08K
Cash From Investing Activities
Cash From Financing Activities 53.90K
Net Change In Cash -16.18K
YoY Change 239.2%
FREE CASH FLOW
Cash From Operating Activities -$70.08K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001888740
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28568 usd
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Revenues
Revenues
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity File Number
EntityFileNumber
333-260873
dei Entity Registrant Name
EntityRegistrantName
LSEB CREATIVE CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-4415385
dei Entity Address Address Line1
EntityAddressAddressLine1
30 N. Gould St. #4000
dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan
dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
701-8561
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15686300 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1988 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4448 usd
CY2024Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
15143 usd
CY2024Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
15143 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1783 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1731 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
125697 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
129992 usd
CY2024Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
178 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
144611 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
151492 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2774 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3242 usd
CY2024Q3 us-gaap Assets
Assets
147385 usd
CY2024Q1 us-gaap Assets
Assets
154734 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5881 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4626 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11877 usd
CY2024Q1 lseb Shares To Be Issued
SharesToBeIssued
2000 usd
CY2024Q3 lseb Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
82816 usd
CY2024Q1 lseb Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
69470 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
104215 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
89228 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15686300 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15686300 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15036300 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15036300 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1569 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1504 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
683471 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
618536 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-641870 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-554534 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
43170 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
65506 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147385 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154734 usd
CY2024Q3 us-gaap Revenues
Revenues
2574 usd
us-gaap Net Income Loss
NetIncomeLoss
-92632 usd
dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 lseb Shares To Be Issued
SharesToBeIssued
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
lseb Increase Decrease In Change In Advances To Suppliers
IncreaseDecreaseInChangeInAdvancesToSuppliers
usd
lseb Proceeds From Issuance Of Shares To Be Issued
ProceedsFromIssuanceOfSharesToBeIssued
usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
usd
CY2024 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
dei Document Type
DocumentType
10-Q
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16773 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Revenues
Revenues
8856 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1061 usd
us-gaap Cost Of Revenue
CostOfRevenue
3701 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1513 usd
us-gaap Gross Profit
GrossProfit
5155 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
5435 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
22074 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
8147 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37970 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9485 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22158 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20020 usd
CY2024Q3 lseb Consulting Expenses
ConsultingExpenses
21713 usd
CY2023Q3 lseb Consulting Expenses
ConsultingExpenses
8536 usd
lseb Consulting Expenses
ConsultingExpenses
43184 usd
lseb Consulting Expenses
ConsultingExpenses
13069 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
15915 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
6732 usd
us-gaap Legal Fees
LegalFees
21280 usd
us-gaap Legal Fees
LegalFees
11024 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
225 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
70 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
468 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
146 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
52773 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
59570 usd
us-gaap Operating Expenses
OperatingExpenses
93099 usd
us-gaap Operating Expenses
OperatingExpenses
90777 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-51260 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-59570 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-87944 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-90777 usd
CY2024Q3 lseb Exchange Gainloss
ExchangeGainloss
-1700 usd
CY2023Q3 lseb Exchange Gainloss
ExchangeGainloss
1771 usd
lseb Exchange Gainloss
ExchangeGainloss
-608 usd
lseb Exchange Gainloss
ExchangeGainloss
1855 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49560 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-61341 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87336 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92632 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-49560 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61341 usd
us-gaap Net Income Loss
NetIncomeLoss
-87336 usd
CY2024Q3 lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0033
CY2023Q3 lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0045
lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0059
lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0069
CY2024Q3 lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
14916228 shares
CY2023Q3 lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
13520696 shares
lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
14916228 shares
lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
13520696 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
65506 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-37776 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
29730 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
40000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-49560 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
43170 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82329 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44200 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-31291 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
99738 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
55199 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61341 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
98096 usd
us-gaap Net Income Loss
NetIncomeLoss
-87336 usd
us-gaap Net Income Loss
NetIncomeLoss
-92632 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
468 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
146 usd
us-gaap Share Based Compensation
ShareBasedCompensation
42000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-52 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4295 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-101920 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
178 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1631 usd
lseb Increase Decrease In Change In Advances To Suppliers
IncreaseDecreaseInChangeInAdvancesToSuppliers
99999 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7251 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5873 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10892 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3815 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36806 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-96726 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
449 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11316 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
13795 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
19159 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
99399 usd
lseb Proceeds From Issuance Of Shares To Be Issued
ProceedsFromIssuanceOfSharesToBeIssued
-2000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34346 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
107242 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2460 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10516 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4448 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2710 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1988 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13226 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_800_eus-gaap--NatureOfOperations_z5iB5NFVLwte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zxgTctUb5SVk">NATURE OF OPERATIONS</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LSEB Creative Corp. was incorporated as “Profit Corporation” on April 3rd, 2019 under Wyoming State regulations with registered office at 1920 Thomes Ave Ste 610, Cheyenne, WY. On August 3, 2023, the Company incorporated its wholly-owned subsidiary 1000615000 Ontario Corp, an Ontario corporation, and on September 12, 2023 filed articles of amendment to changed its name to LSEB Creative Corp (Ontario). The purpose of the subsidiary is for GST/HST tax credits on importing goods into Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LSEB Creative Corp. is a specialty retailer that offers men and women elevated swimwear designs, constructed with the highest quality materials and techniques. Our product concept focuses on coordinating items within the men’s and women’s sub-categories, which allows customers the ability to coordinate with their partner. It’s this concept, along with our noteworthy fabrics, construction techniques, and “ready-to-wear” inspired designs that will allow LSEB to capture a new space within the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its aim is to become a leading retailer in the global luxury fashion industry. The corporation is currently involved in concept, design, manufacturing, and distribution of its products with emphasis on its swimwear category. The Company operates under the web-site address lsebcreative.com and its e-commerce platform laurenbentleyswim.com which is complete, and the Company launched the brand in October 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1988 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4448 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEmMucjD9VD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zMIQNth5HZ8j">Reclassification</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified for comparative purposes to conform to the current year financial statement presentation. These reclassifications had no effect on previous reported results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
5435 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
22074 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zCBX4RbHaWSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zjohaIGgG0C6">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of audited financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include deferred income tax assets and related valuation allowance, valuation of convertible notes, warrants and accruals. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.</span></p>
CY2024Q3 us-gaap Inventory Net
InventoryNet
125697 usd
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_842_eus-gaap--RevenueRecognitionDeferredRevenue_zDPFvCH04gIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zuiyJxji1Fnf">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC-606 by,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 29px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 29px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying the contract(s) with a customer,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying the performance obligations in the contract,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining the transaction price,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocating the transaction price to the performance obligations in the contract and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognizing revenue when the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, the Company recognizes revenue when performance obligations under the terms of the contracts are satisfied. Our performance obligations primarily consist of delivering products to our customers. Control is transferred upon providing the products to customers upon shipment of our products to the consumers from our ecommerce sites. Once control is transferred to the customer, we have completed our performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
15143 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5692 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2024 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2948 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5692 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5692 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2450 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1737 usd
us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
468 usd
CY2024 us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
713 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2918 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2450 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2774 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3242 usd
CY2024Q3 lseb Accounts Payable Related Parties Current1
AccountsPayableRelatedPartiesCurrent1
82816 usd
CY2024Q1 lseb Accounts Payable Related Parties Current1
AccountsPayableRelatedPartiesCurrent1
69470 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
4000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15686300 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15686300 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3700 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4500 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7500 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4700 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
500 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
380 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2024Q1 lseb Proceeds From Issuance Of Shares To Be Issued
ProceedsFromIssuanceOfSharesToBeIssued
2000 usd
CY2024Q2 lseb Proceeds From Issuance Of Shares To Be Issued
ProceedsFromIssuanceOfSharesToBeIssued
20000 usd

Files In Submission

Name View Source Status
0001199835-24-000522-index-headers.html Edgar Link pending
0001199835-24-000522-index.html Edgar Link pending
0001199835-24-000522.txt Edgar Link pending
0001199835-24-000522-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lseb-10q.htm Edgar Link pending
lseb-20240930.xsd Edgar Link pending
lseb-ex31_1.htm Edgar Link pending
lseb-ex31_2.htm Edgar Link pending
lseb-ex32_1.htm Edgar Link pending
lseb-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lseb-20240930_def.xml Edgar Link unprocessable
lseb-20240930_lab.xml Edgar Link unprocessable
lseb-20240930_pre.xml Edgar Link unprocessable
lseb-10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
lseb-20240930_cal.xml Edgar Link unprocessable